The Application of Micro/Nanorobots in Cancer Therapy.
- 2026-05-15
- Micromachines 17(5)
- Yinglei Zhang
- Bo Yang
- Xiang Zou
- PubMed: 42195529
- DOI: 10.3390/mi17050612
Study Design
- Type
- Review
- Methods
- This review systematically analyzes recent advancements in MNR applications
Cancer continues to present a profound challenge due to high mortality and the inherent limitations of conventional treatments, including suboptimal targeting, systemic toxicity, and difficulty in overcoming physiological barriers. Micro/nanorobots (MNRs) offer a promising enhanced precision and efficacy in cancer therapy. This review systematically analyzes recent advancements in MNR applications, establishing a consistent framework that interlinks their diverse material compositions, propulsion strategies, and therapeutic functions. We critically compare various materials (inorganic, organic/polymeric, and biological/hybrid materials), elucidating their respective trade-offs in biocompatibility, biodegradability, and stimulus responsiveness. This paper further examines both internal (chemical and biological) and external (magnetic, light, and ultrasound) propulsion mechanisms, highlighting their strengths in overcoming biological barriers and enabling complex in vivo navigation, while also discussing their inherent limitations in control, fuel dependency, and tissue penetration. We then synthesize the therapeutic capabilities of MNRs across targeted drug delivery, phototherapy, radiotherapy, and immunotherapy, emphasizing common advantages like enhanced tumor specificity and reduced systemic side effects. A forward-looking perspective was also provided on the remaining challenges, particularly focusing on in vivo controllability, long-term biosafety, manufacturing scalability, and the significant hurdles in clinical translation. By offering a more critical and integrated analysis, this review underscores the immense potential of MNRs to revolutionize personalized precision cancer treatment, while candidly addressing the complex obstacles that must be surmounted for their successful clinical adoption.